Washington SB 5723: Concerning improving diversity in clinical trials.

Status: By resolution, returned to Senate Rules Committee for third reading. (as of 2022-03-10)

State: Washington · Session: 2021-2022 · Bill: SB 5723

Subjects: DRUGS, HEALTH CARE, INSTITUTIONAL REVIEW BOARD, WASHINGTON STATE, MINORITIES, WOMEN

Sponsors: Rivers, Keiser, Lovick

View Washington SB 5723 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.